
Mustafa Raoof
@mustafaraoofmd
Cancer surgeon and researcher @cityofhope interested in pancreas, bile duct, liver and peritoneal cancers. Studying #replicationstress #DNAdamageresponse
ID: 726861731171954688
https://www.cityofhope.org/mustafa-raoof 01-05-2016 19:51:55
2,2K Tweet
1,1K Takipçi
704 Takip Edilen

Upfront resection vs no resection of the primary tumor in metastatic colorectal cancer Annals of Oncology doi.org/10.1016/j.anno… 🔎Phs 3 CAIRO4, 206 pts 👉mOS 18.3 vs 20.1 mo 👉AEs ≥3° 72% vs 65% 🧐Upfront PTR to palliative systemic therapy does not improve survival ESMO - Eur. Oncology



Happy to announce our second PIPAC training course taking place in July 28 and 29, 2024 at City of Hope, CA. cme.cityofhope.org/content/second… Mustafa Raoof ISSPP Amit Merchea Division of Gynecologic Oncology at City of Hope City of Hope Surgery


Join us for the next #PIPAC training course. City of Hope Mayo Clinic & Northwell Health are running the only US clinical trial. Learn the technique and hear about what’s coming! Mayo Clinic Comprehensive Cancer Center Mayo Clinic Department of Surgery ASCRS_1 DCRjournal Mustafa Raoof Thanh Dellinger Danielle DePeralta

Researchers at City of Hope are advancing treatment for advanced prostate cancer with immunotherapy. Early results from a phase 1 trial using CAR T cell therapy showed minimal side effects and promising activity, as reported in Nature Medicine. cityofhope.org/study-car-t-pr…


Excellent SURGERY Journal contribution by City of Hope Surgical Oncology M. Talha Waheed @AMBlakely Helmi Mustafa Raoof Andreas M Kaiser MD Laleh Melstrom Mark Hanna surgjournal.com/article/S0039-…


PIPAC-Ox vs. 3rd-line standard therapy for CRC & AC carcinomatosis in Annals of Surgical Oncology Promising future for PIPAC ⬆️ Good days- days alive & outside 🏥 ⬆️ OS- 11.3 vs. 5.1 mo ⬆️ PFS- 2.9 vs. 2.1 mo: NS Next step ❓Randomized Trial ! Mustafa Raoof Thanh Dellinger City of Hope Surgical Oncology


Strong City of Hope Surgical Oncology presence at #ACT25 Society of Surgical Oncology ! 3 faculty panels 6 abstracts: 4 podiums, 2 posters ! Great meeting and so much learning ! Grateful to my mentor & sponsor Mustafa Raoof and the team at City of Hope Surgery ! Laleh Melstrom Kevin Labadie Helmi


Brilliant presentation by Mustafa Raoof safety and efficacy PIPAC -appendiceal/colorectal ca-drop in PCI and CEA. This has promise to change the field Society of Surgical Oncology Yuman Fong


What a huge honor to be recognized by nursing and leadership as the physician of the year ! Still got it Dr Fong! Yuman Fong City of Hope City of Hope Surgery


Future research will aim to assess the efficacy of PIPAC-MMC plus systemic therapy vs systemic therapy alone in patients with peritoneal tumors. #crcsm | Mustafa Raoof hubs.li/Q03f_D0_0

Paper of the day 🔥 Feasibility of Robotic Surgical Approach in Peritoneal Carcinomatosis sciencedirect.com/science/articl… Mustafa Raoof Yuman Fong

On the next episode of On the Edge of Breakthrough: Voices of Cancer Research, City of Hope surgical oncologist Dr. Mustafa Raoof and Sumanta K. Pal, MD, FASCO discuss emerging surgical techniques in pancreatic and peritoneal cancers. Stream the episode tomorrow on Apple Podcasts and Spotify!

Our latest episode of the City of Hope podcast is out!!! Was delighted to interview the one & only Mustafa Raoof, who is developing an international reputation for innovative techniques like #PIPAC. We dive deep into the mind of a surgeon-scientist - have a listen! Yuman Fong

City of Hope researchers used an investigational City of Hope-developed drug, AOH1996, to target transcription-replication conflicts in pancreatic cancer. In a study just published in Gastroenterology, two participants saw liver metastases shrink by up to 49%. bit.ly/42BHN2b


Excited to see this PanCAN-funded study published in Gastroenterology, highlighting an investigational approach currently being evaluated in patients with #pancreaticcancer. Congratulations to Mustafa Raoof and the team at @CityofHope on this important advancement!

new results from our lab at #AACR25 next week: Muhammad Talha Nawaz will show how peritoneal fluid tumor DNA (yes, ptDNA) can help detect and monitor response to therapy in patients with peritoneal metastasis, collaboration with Mustafa Raoof abstractsonline.com/pp8/#!/20273/p…
